Differentially expressed immune response genes in COVID-19 patients based on disease severity
Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease 2019 (COVID-19). We sought to further characterize host antiviral and cytokine gene expression in COVID-19 patients based on illness severity....
Saved in:
| Published in | Aging (Albany, NY.) Vol. 13; no. 7; pp. 9265 - 9276 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Impact Journals
15.04.2021
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1945-4589 1945-4589 |
| DOI | 10.18632/aging.202877 |
Cover
| Abstract | Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease 2019 (COVID-19). We sought to further characterize host antiviral and cytokine gene expression in COVID-19 patients based on illness severity.
In this case-control study, we retrospectively analyzed 46 recovered COVID-19 patients and 24 healthy subjects (no history of COVID-19) recruited from the Second People's Hospital of Fuyang City. Blood samples were collected from each study participant for RNA extraction and PCR. We assessed changes in antiviral gene expression between healthy controls and patients with mild/moderate (MM) and severe/critical (SC) disease.
We found that type I interferon signaling (IFNA2, TLR8, IFNA1, IFNAR1, TLR9, IRF7, ISG15, APOBEC3G, and MX1) and genes encoding proinflammatory cytokines (IL12B, IL15, IL6, IL12A and IL1B) and chemokines (CXCL9, CXCL11 and CXCL10) were upregulated in patients with MM and SC disease. Moreover, we found that IFNA1, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), and Fas-associated protein with death domain (FADD) were significantly downregulated (
< 0.05) in the SC group compared to the MM group. We also observed that microRNA (miR)-155 and miR-130a levels were markedly higher in the MM group compared to the SC group.
COVID-19 is associated with the activation of host antiviral genes. Induction of the IFN system appears to be particularly important in controlling SARS-CoV-2 infection, as decreased expression of IFNA1, APOBEC3G and FADD genes in SC patients, relative to MM patients, may be associated with disease progression. |
|---|---|
| AbstractList | Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease 2019 (COVID-19). We sought to further characterize host antiviral and cytokine gene expression in COVID-19 patients based on illness severity.BACKGROUNDDysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease 2019 (COVID-19). We sought to further characterize host antiviral and cytokine gene expression in COVID-19 patients based on illness severity.In this case-control study, we retrospectively analyzed 46 recovered COVID-19 patients and 24 healthy subjects (no history of COVID-19) recruited from the Second People's Hospital of Fuyang City. Blood samples were collected from each study participant for RNA extraction and PCR. We assessed changes in antiviral gene expression between healthy controls and patients with mild/moderate (MM) and severe/critical (SC) disease.METHODSIn this case-control study, we retrospectively analyzed 46 recovered COVID-19 patients and 24 healthy subjects (no history of COVID-19) recruited from the Second People's Hospital of Fuyang City. Blood samples were collected from each study participant for RNA extraction and PCR. We assessed changes in antiviral gene expression between healthy controls and patients with mild/moderate (MM) and severe/critical (SC) disease.We found that type I interferon signaling (IFNA2, TLR8, IFNA1, IFNAR1, TLR9, IRF7, ISG15, APOBEC3G, and MX1) and genes encoding proinflammatory cytokines (IL12B, IL15, IL6, IL12A and IL1B) and chemokines (CXCL9, CXCL11 and CXCL10) were upregulated in patients with MM and SC disease. Moreover, we found that IFNA1, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), and Fas-associated protein with death domain (FADD) were significantly downregulated (P < 0.05) in the SC group compared to the MM group. We also observed that microRNA (miR)-155 and miR-130a levels were markedly higher in the MM group compared to the SC group.RESULTSWe found that type I interferon signaling (IFNA2, TLR8, IFNA1, IFNAR1, TLR9, IRF7, ISG15, APOBEC3G, and MX1) and genes encoding proinflammatory cytokines (IL12B, IL15, IL6, IL12A and IL1B) and chemokines (CXCL9, CXCL11 and CXCL10) were upregulated in patients with MM and SC disease. Moreover, we found that IFNA1, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), and Fas-associated protein with death domain (FADD) were significantly downregulated (P < 0.05) in the SC group compared to the MM group. We also observed that microRNA (miR)-155 and miR-130a levels were markedly higher in the MM group compared to the SC group.COVID-19 is associated with the activation of host antiviral genes. Induction of the IFN system appears to be particularly important in controlling SARS-CoV-2 infection, as decreased expression of IFNA1, APOBEC3G and FADD genes in SC patients, relative to MM patients, may be associated with disease progression.CONCLUSIONCOVID-19 is associated with the activation of host antiviral genes. Induction of the IFN system appears to be particularly important in controlling SARS-CoV-2 infection, as decreased expression of IFNA1, APOBEC3G and FADD genes in SC patients, relative to MM patients, may be associated with disease progression. Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease 2019 (COVID-19). We sought to further characterize host antiviral and cytokine gene expression in COVID-19 patients based on illness severity. In this case-control study, we retrospectively analyzed 46 recovered COVID-19 patients and 24 healthy subjects (no history of COVID-19) recruited from the Second People's Hospital of Fuyang City. Blood samples were collected from each study participant for RNA extraction and PCR. We assessed changes in antiviral gene expression between healthy controls and patients with mild/moderate (MM) and severe/critical (SC) disease. We found that type I interferon signaling (IFNA2, TLR8, IFNA1, IFNAR1, TLR9, IRF7, ISG15, APOBEC3G, and MX1) and genes encoding proinflammatory cytokines (IL12B, IL15, IL6, IL12A and IL1B) and chemokines (CXCL9, CXCL11 and CXCL10) were upregulated in patients with MM and SC disease. Moreover, we found that IFNA1, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), and Fas-associated protein with death domain (FADD) were significantly downregulated ( < 0.05) in the SC group compared to the MM group. We also observed that microRNA (miR)-155 and miR-130a levels were markedly higher in the MM group compared to the SC group. COVID-19 is associated with the activation of host antiviral genes. Induction of the IFN system appears to be particularly important in controlling SARS-CoV-2 infection, as decreased expression of IFNA1, APOBEC3G and FADD genes in SC patients, relative to MM patients, may be associated with disease progression. Background: Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease 2019 (COVID-19). We sought to further characterize host antiviral and cytokine gene expression in COVID-19 patients based on illness severity. Methods: In this case-control study, we retrospectively analyzed 46 recovered COVID-19 patients and 24 healthy subjects (no history of COVID-19) recruited from the Second People's Hospital of Fuyang City. Blood samples were collected from each study participant for RNA extraction and PCR. We assessed changes in antiviral gene expression between healthy controls and patients with mild/moderate (MM) and severe/critical (SC) disease. Results: We found that type I interferon signaling (IFNA2, TLR8, IFNA1, IFNAR1, TLR9, IRF7, ISG15, APOBEC3G, and MX1) and genes encoding proinflammatory cytokines (IL12B, IL15, IL6, IL12A and IL1B) and chemokines (CXCL9, CXCL11 and CXCL10) were upregulated in patients with MM and SC disease. Moreover, we found that IFNA1, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), and Fas-associated protein with death domain (FADD) were significantly downregulated (P < 0.05) in the SC group compared to the MM group. We also observed that microRNA (miR)-155 and miR-130a levels were markedly higher in the MM group compared to the SC group. Conclusion: COVID-19 is associated with the activation of host antiviral genes. Induction of the IFN system appears to be particularly important in controlling SARS-CoV-2 infection, as decreased expression of IFNA1, APOBEC3G and FADD genes in SC patients, relative to MM patients, may be associated with disease progression. |
| Author | Jeyarajan, Andre J. Li, Ming Han, Mingfeng Li, Yujia Li, Xiuyong Li, Shilin Tan, Lin Chen, Limin Lin, Wenyu Duan, Xiaoqiong Li, Shasha Li, Tuantuan Gao, Yong Shao, Tuo |
| Author_xml | – sequence: 1 givenname: Shasha surname: Li fullname: Li, Shasha organization: Department of Hepatology, The Second People's Hospital of Fuyang City, Fuyang 236015, Anhui Province, P.R. of China, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang 236015, Anhui Province, P.R. of China – sequence: 2 givenname: Xiaoqiong surname: Duan fullname: Duan, Xiaoqiong organization: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu 610052, Sichuan Province, P.R. of China – sequence: 3 givenname: Yujia surname: Li fullname: Li, Yujia organization: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu 610052, Sichuan Province, P.R. of China – sequence: 4 givenname: Ming surname: Li fullname: Li, Ming organization: Department of Hepatology, The Second People's Hospital of Fuyang City, Fuyang 236015, Anhui Province, P.R. of China, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang 236015, Anhui Province, P.R. of China – sequence: 5 givenname: Yong surname: Gao fullname: Gao, Yong organization: Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang 236015, Anhui Province, P.R. of China, Clinical laboratory, The Second People's Hospital of Fuyang City, Fuyang 236015, Anhui Province, P.R. of China – sequence: 6 givenname: Tuantuan surname: Li fullname: Li, Tuantuan organization: Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang 236015, Anhui Province, P.R. of China, Clinical laboratory, The Second People's Hospital of Fuyang City, Fuyang 236015, Anhui Province, P.R. of China – sequence: 7 givenname: Shilin surname: Li fullname: Li, Shilin organization: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu 610052, Sichuan Province, P.R. of China – sequence: 8 givenname: Lin surname: Tan fullname: Tan, Lin organization: Department of Hepatology, The Second People's Hospital of Fuyang City, Fuyang 236015, Anhui Province, P.R. of China, Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang 236015, Anhui Province, P.R. of China – sequence: 9 givenname: Tuo surname: Shao fullname: Shao, Tuo organization: Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA – sequence: 10 givenname: Andre J. surname: Jeyarajan fullname: Jeyarajan, Andre J. organization: Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA – sequence: 11 givenname: Limin surname: Chen fullname: Chen, Limin organization: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu 610052, Sichuan Province, P.R. of China – sequence: 12 givenname: Mingfeng surname: Han fullname: Han, Mingfeng organization: Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang 236015, Anhui Province, P.R. of China, Department of Pneumology, The Second People's Hospital of Fuyang City, Fuyang 236015, Anhui Province, P.R. of China – sequence: 13 givenname: Wenyu surname: Lin fullname: Lin, Wenyu organization: Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA – sequence: 14 givenname: Xiuyong surname: Li fullname: Li, Xiuyong organization: Fuyang Infectious Disease Clinical College of Anhui Medical University, Fuyang 236015, Anhui Province, P.R. of China, Hemodialysis center, The Second People's Hospital of Fuyang City, Fuyang 236015, Anhui Province, P.R. of China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33780352$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUtv3CAUhVGUKq92mW3FshtPgAvG3lSqJn1EipRNm12EsOd6QmWDA3ba-fclmTSPSumKizjfPTqHQ7Lrg0dCjjlb8KoEcWLXzq8XgolK6x1ywGupCqmqevfZvE8OU_rJWKmULPfIPoCuGChxQK5OXddhRD852_cbir_HiCnhirphmD3SfBuDT0jX6DFR5-ny4vLstOA1He3kMphoY--A4OnKJcwzTXiL0U2bt-RNZ_uE7x7OI_Ljy-fvy2_F-cXXs-Wn86KFSk8F6EZyrFgNnHNbN9BxCyBBdQhatsCYANEwUVqlobGVRCuaGpheNbVmjMERWWz3zn60m185iRmjG2zcGM7MfU_mviez7SkDH7fAODcDrtocI9onKFhnXr54d23W4dZUrJSCq7zgw8OCGG5mTJMZXGqx763HMCcjFNNcZjVk6fvnXo8mfz8hC2AraGNIKWJnWjflbsOdtetfjVD8Q_0_8h--vqsT |
| CitedBy_id | crossref_primary_10_1007_s11033_024_09630_2 crossref_primary_10_2147_IDR_S372420 crossref_primary_10_3390_nu13114047 crossref_primary_10_1016_j_genrep_2022_101641 crossref_primary_10_3389_fmicb_2022_1007295 crossref_primary_10_1039_D2SD00140C crossref_primary_10_1515_tjb_2024_0139 crossref_primary_10_1007_s00011_023_01791_3 crossref_primary_10_1186_s12879_022_07219_3 crossref_primary_10_5005_jp_journals_10018_1414 crossref_primary_10_4103_abr_abr_232_22 crossref_primary_10_1016_j_clim_2022_109068 crossref_primary_10_1002_rmv_2449 crossref_primary_10_1007_s13577_023_00867_w crossref_primary_10_1111_febs_16230 crossref_primary_10_3390_biom12121735 crossref_primary_10_1038_s41598_024_81803_2 crossref_primary_10_1016_j_intimp_2023_110333 crossref_primary_10_3389_fimmu_2022_918692 crossref_primary_10_54033_cadpedv20n4_015 crossref_primary_10_1016_j_virusres_2022_198880 crossref_primary_10_4103_jad_jad_64_24 crossref_primary_10_3390_life12020288 crossref_primary_10_3389_fmed_2021_770836 crossref_primary_10_1016_j_gene_2022_146647 crossref_primary_10_1073_pnas_2406773121 crossref_primary_10_1016_j_imbio_2021_152130 crossref_primary_10_1097_MEG_0000000000002750 crossref_primary_10_2217_bmm_2021_0348 |
| Cites_doi | 10.18632/aging.104024 10.1002/jmv.25699 10.1016/j.jcv.2020.104392 10.1128/mBio.01928-20 10.1002/hep.29921 10.1126/science.abd4570 10.1016/S0140-6736(20)30186-0 10.1016/S0140-6736(20)30154-9 10.1186/s12931-016-0474-9 10.1128/JVI.02009-17 10.1056/NEJMoa2001316 10.18632/aging.104147 10.1007/s40290-020-00342-z 10.3389/fimmu.2017.01932 10.1016/j.jhep.2020.04.006 10.1016/S0140-6736(20)30211-7 10.1016/j.intimp.2020.107082 10.18632/aging.103931 10.1016/j.ajhg.2010.10.028 10.3390/cells8040338 10.18632/aging.103720 10.1016/j.jhep.2014.11.038 10.1001/jama.2020.1585 10.1016/j.ebiom.2020.103026 10.3390/v11010059 10.1111/resp.13196 10.1186/s12976-019-0112-6 10.1016/j.immuni.2020.05.004 10.1111/jvh.12390 10.1073/pnas.1706928115 10.1016/j.ijid.2020.10.003 10.1038/s41598-018-24448-2 10.1016/j.immuni.2012.12.006 10.4178/epih.e2020007 10.1007/978-3-642-27340-7_9 10.1002/jmv.25678 10.1038/s41586-020-2012-7 10.1016/j.ijid.2020.01.009 10.1002/hep.26653 10.18632/aging.202362 10.1016/S1473-3099(20)30120-1 10.4049/jimmunol.1201184 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2021 Li et al. |
| Copyright_xml | – notice: Copyright: © 2021 Li et al. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
| DOI | 10.18632/aging.202877 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1945-4589 |
| EndPage | 9276 |
| ExternalDocumentID | 10.18632/aging.202877 PMC8064215 33780352 10_18632_aging_202877 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI155140 |
| GroupedDBID | --- 53G AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z FRP GX1 HYE KQ8 M48 O5R O5S OK1 PGMZT RPM W2D CGR CUY CVF ECM EIF NPM 7X8 5PM ADRAZ ADTOC UNPAY |
| ID | FETCH-LOGICAL-c387t-37b41e8093111a9b3f1a33435fe374c300232b026a573ba84ea2b9307db970003 |
| IEDL.DBID | M48 |
| ISSN | 1945-4589 |
| IngestDate | Tue Aug 19 23:57:34 EDT 2025 Tue Sep 30 16:54:11 EDT 2025 Thu Jul 10 18:12:20 EDT 2025 Thu Jan 02 22:56:44 EST 2025 Tue Jul 01 00:38:19 EDT 2025 Thu Apr 24 23:06:23 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 7 |
| Keywords | COVID-19 IL6 SARS-CoV-2 immune response genes APOBEC3G |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c387t-37b41e8093111a9b3f1a33435fe374c300232b026a573ba84ea2b9307db970003 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Equal contribution |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.18632/aging.202877 |
| PMID | 33780352 |
| PQID | 2507148063 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | unpaywall_primary_10_18632_aging_202877 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8064215 proquest_miscellaneous_2507148063 pubmed_primary_33780352 crossref_citationtrail_10_18632_aging_202877 crossref_primary_10_18632_aging_202877 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-04-15 |
| PublicationDateYYYYMMDD | 2021-04-15 |
| PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Aging (Albany, NY.) |
| PublicationTitleAlternate | Aging (Albany NY) |
| PublicationYear | 2021 |
| Publisher | Impact Journals |
| Publisher_xml | – name: Impact Journals |
| References | Gardner (16) 2020; 2 Peng (8) 2020; 32 Chowell (29) 2019; 1 Ye (26) 2020; 37 Petersen (13) 2020; 9 Pyrc (33) 2018; 8 Ghany (35) 2018; 6 Hale (40) 2020; 1 Bosco (19) 2016; 1 Tang (12) 2020; 9 Fatima (36) 2020; 3 Chen (42) 2019; 8 He (15) 2020; 7 Kurowska-Stolarska (41) 2018; 8 Qin (3) 2019; 1 Rufer (31) 2013; 3 Tang (39) 2020; 12 The (4) 2020; 39 Ki (9) 2020; 4 Salloum (32) 2018; 9 Zhang (1) 2020; 39 Liu (17) 2020; 1 Corazza (37) 2020; 10 Liu (21) 2020; 1 Chan (11) 2020; 39 Rice (34) 2013; 36 Cant (28) 2010; 8 Wu (14) 2020; 38 Luo (20) 2020; 57 Han (6) 2020; 1 Ciccozzi (10) 2020; 9 Sun (22) 2020; 1 Chung (23) 2015; 6 Wunderink (5) 2018; 2 McElvaney (38) 2020; 6 Kumthip (24) 2014; 5 Mahanty (7) 2020; 5 Chakravarty (30) 2015; 2 Guo (18) 2020; 1 Mohammadi (25) 2020; 8 Spetz (27) 2013; 19 Webb-Robertson (2) 2018; 11 |
| References_xml | – volume: 1 start-page: 20938 year: 2020 ident: 17 article-title: Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses. publication-title: Aging (Albany NY) doi: 10.18632/aging.104024 – volume: 9 start-page: 518 year: 2020 ident: 10 article-title: The first two cases of 2019-nCoV in Italy: where they come from? publication-title: J Med Virol doi: 10.1002/jmv.25699 – volume: 12 start-page: 104392 year: 2020 ident: 39 article-title: Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China. publication-title: J Clin Virol doi: 10.1016/j.jcv.2020.104392 – volume: 1 start-page: e01928 year: 2020 ident: 40 article-title: Antiviral activity of type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2. publication-title: mBio doi: 10.1128/mBio.01928-20 – volume: 6 start-page: 2078 year: 2018 ident: 35 article-title: Baseline intrahepatic and peripheral innate immunity are associated with hepatitis C virus clearance during direct-acting antiviral therapy. publication-title: Hepatology doi: 10.1002/hep.29921 – volume: 37 start-page: eabd4570 year: 2020 ident: 26 article-title: Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. publication-title: Science doi: 10.1126/science.abd4570 – volume: 39 start-page: 311 year: 2020 ident: 4 article-title: Emerging understandings of 2019-nCoV. publication-title: Lancet doi: 10.1016/S0140-6736(20)30186-0 – volume: 39 start-page: 514 year: 2020 ident: 11 article-title: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. publication-title: Lancet doi: 10.1016/S0140-6736(20)30154-9 – volume: 1 start-page: 156 year: 2016 ident: 19 article-title: Respiratory viral infections and host responses; insights from genomics. publication-title: Respir Res doi: 10.1186/s12931-016-0474-9 – volume: 9 start-page: e02009 year: 2018 ident: 32 article-title: MicroRNA 130a regulates both hepatitis C virus and hepatitis B virus replication through a central metabolic pathway. publication-title: J Virol doi: 10.1128/JVI.02009-17 – volume: 38 start-page: 1199 year: 2020 ident: 14 article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. publication-title: N Engl J Med doi: 10.1056/NEJMoa2001316 – volume: 1 start-page: 22370 year: 2020 ident: 18 article-title: Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer. publication-title: Aging (Albany NY) doi: 10.18632/aging.104147 – volume: 3 start-page: 223 year: 2020 ident: 36 article-title: IL-6 inhibitors in the treatment of serious COVID-19: a promising therapy? publication-title: Pharmaceut Med doi: 10.1007/s40290-020-00342-z – volume: 8 start-page: 1932 year: 2018 ident: 41 article-title: MicroRNA-155-at the critical interface of innate and adaptive immunity in arthritis. publication-title: Front Immunol doi: 10.3389/fimmu.2017.01932 – volume: 7 start-page: 566 year: 2020 ident: 15 article-title: COVID-19: abnormal liver function tests. publication-title: J Hepatol doi: 10.1016/j.jhep.2020.04.006 – volume: 39 start-page: 507 year: 2020 ident: 1 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. publication-title: Lancet doi: 10.1016/S0140-6736(20)30211-7 – volume: 8 start-page: 107082 year: 2020 ident: 25 article-title: Recent findings on the coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics. publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2020.107082 – volume: 1 start-page: 18853 year: 2020 ident: 22 article-title: Clinical characteristics and prognostic factors of COVID-19 patients progression to severe: a retrospective, observational study. publication-title: Aging (Albany NY) doi: 10.18632/aging.103931 – volume: 8 start-page: 873 year: 2010 ident: 28 article-title: Whole-exome-sequencing-based discovery of human FADD deficiency. publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2010.10.028 – volume: 8 start-page: 338 year: 2019 ident: 42 article-title: Microrna-130a downregulates HCV replication through an atg5-dependent autophagy pathway. publication-title: Cells doi: 10.3390/cells8040338 – volume: 1 start-page: 13895 year: 2020 ident: 6 article-title: COVID-19 induced liver function abnormality associates with age. publication-title: Aging (Albany NY) doi: 10.18632/aging.103720 – volume: 6 start-page: 1024 year: 2015 ident: 23 article-title: The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing. publication-title: J Hepatol doi: 10.1016/j.jhep.2014.11.038 – volume: 32 start-page: 1061 year: 2020 ident: 8 article-title: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. publication-title: JAMA doi: 10.1001/jama.2020.1585 – volume: 6 start-page: 103026 year: 2020 ident: 38 article-title: A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.103026 – volume: 1 start-page: 59 year: 2019 ident: 3 article-title: From SARS to MERS, thrusting coronaviruses into the spotlight. publication-title: Viruses doi: 10.3390/v11010059 – volume: 2 start-page: 130 year: 2018 ident: 5 article-title: MERS, SARS and other coronaviruses as causes of pneumonia. publication-title: Respirology doi: 10.1111/resp.13196 – volume: 1 start-page: 16 year: 2019 ident: 29 article-title: Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting. publication-title: Theor Biol Med Model doi: 10.1186/s12976-019-0112-6 – volume: 5 start-page: 905 year: 2020 ident: 7 article-title: Respiratory virus infections: understanding COVID-19. publication-title: Immunity doi: 10.1016/j.immuni.2020.05.004 – volume: 2 start-page: 817 year: 2015 ident: 30 article-title: Expression of microRNA-155 correlates positively with the expression of toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes. publication-title: J Viral Hepat doi: 10.1111/jvh.12390 – volume: 11 start-page: E1012 year: 2018 ident: 2 article-title: MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape. publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1706928115 – volume: 10 start-page: 342 year: 2020 ident: 37 article-title: A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.10.003 – volume: 8 start-page: 5960 year: 2018 ident: 33 article-title: APOBEC3-mediated restriction of RNA virus replication. publication-title: Sci Rep doi: 10.1038/s41598-018-24448-2 – volume: 3 start-page: 742 year: 2013 ident: 31 article-title: MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. publication-title: Immunity doi: 10.1016/j.immuni.2012.12.006 – volume: 4 start-page: e2020007 year: 2020 ident: 9 article-title: Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. publication-title: Epidemiol Health doi: 10.4178/epih.e2020007 – volume: 36 start-page: 219 year: 2013 ident: 34 article-title: Innate immune responses to hepatitis C virus. publication-title: Curr Top Microbiol Immunol doi: 10.1007/978-3-642-27340-7_9 – volume: 9 start-page: 401 year: 2020 ident: 12 article-title: Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. publication-title: J Med Virol doi: 10.1002/jmv.25678 – volume: 57 start-page: 270 year: 2020 ident: 20 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin. publication-title: Nature doi: 10.1038/s41586-020-2012-7 – volume: 9 start-page: 264 year: 2020 ident: 13 article-title: The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.01.009 – volume: 5 start-page: 1250 year: 2014 ident: 24 article-title: Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. publication-title: Hepatology doi: 10.1002/hep.26653 – volume: 1 start-page: 24596 year: 2020 ident: 21 article-title: Dynamic monitoring of immune function indexes in COVID-19 patients. publication-title: Aging (Albany NY) doi: 10.18632/aging.202362 – volume: 2 start-page: 533 year: 2020 ident: 16 article-title: An interactive web-based dashboard to track COVID-19 in real time. publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(20)30120-1 – volume: 19 start-page: 3346 year: 2013 ident: 27 article-title: IFN-α induces APOBEC3G, F, and a in immature dendritic cells and limits HIV-1 spread to CD4+ T cells. publication-title: J Immunol doi: 10.4049/jimmunol.1201184 |
| SSID | ssj0065546 |
| Score | 2.4377553 |
| Snippet | Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease... Background: Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of... |
| SourceID | unpaywall pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 9265 |
| SubjectTerms | Adult Aged APOBEC-3G Deaminase - genetics APOBEC-3G Deaminase - immunology Case-Control Studies COVID-19 - genetics COVID-19 - immunology Cytokines - genetics Cytokines - immunology Female Humans Immunity, Innate Interferon Type I - genetics Interferon Type I - immunology Male Middle Aged Research Paper Retrospective Studies SARS-CoV-2 - immunology Severity of Illness Index Transcriptome Up-Regulation |
| Title | Differentially expressed immune response genes in COVID-19 patients based on disease severity |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33780352 https://www.proquest.com/docview/2507148063 https://pubmed.ncbi.nlm.nih.gov/PMC8064215 https://www.aging-us.com/article/202877/pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 13 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1945-4589 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0065546 issn: 1945-4589 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1945-4589 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0065546 issn: 1945-4589 databaseCode: DIK dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1945-4589 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0065546 issn: 1945-4589 databaseCode: GX1 dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1945-4589 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0065546 issn: 1945-4589 databaseCode: RPM dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1945-4589 dateEnd: 20250831 omitProxy: true ssIdentifier: ssj0065546 issn: 1945-4589 databaseCode: M48 dateStart: 20090101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7RItpeKihQwqMyEoILKUnsxPahQqilFKSFC4v2giI7cdqVomzZh-j-e2YSb2i1lHOch_J5Zr6RZ74BeFUaaUqBaYkm4VZRlDLUmRShSm1S6KgQpaFG4cHX7GwovozS0V9JIf8DZ_9M7Wie1HBaH179Wr5Hgz8ig1cZT96183ww10P2LzfgLgalhDb4QPQHChkVY3mJzbVbdmCLc6mitvvoenRao5zrlZPbi-bSLH-bur4Wlk7vw67nk-xDtwEewB3X7MG9bsLkcg-2Bv7s_CH8PPGzUNCm63rJ3FVbA-tKNqYeEcemXbmsY-fk_9i4Ycfffnw-CWPNvPrqjFHQK9mkYf5gh2FgdTT_7hEMTz9-Pz4L_XCFsEBU5uhYrIidijRHb2e05VVsOEfyVDkuRcEpmCcWMzSTSm6NEs4kVqNHKK2WlEk9hs1m0rgnwEwcF7pKkHhoIaLC2NRoIbPIlpWulFEBvF391LzwyuM0AKPOKQMhOPIWjryDI4DX_fLLTnLjtoUvVwjlaBR00mEaN1nM8oRYrlBIvwLY7xDrH7WCOgB5A8t-AQlu37zSjC9a4W3VtgWnAbzpUf__Fz699e3PYCeh6hhSjUyfw-Z8unAvkN7M7QFsfBrFB-32_QNxAvmC |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differentially+expressed+immune+response+genes+in+COVID-19+patients+based+on+disease+severity&rft.jtitle=Aging+%28Albany%2C+NY.%29&rft.au=Li%2C+Shasha&rft.au=Duan%2C+Xiaoqiong&rft.au=Li%2C+Yujia&rft.au=Li%2C+Ming&rft.date=2021-04-15&rft.eissn=1945-4589&rft.volume=13&rft.issue=7&rft.spage=9265&rft_id=info:doi/10.18632%2Faging.202877&rft_id=info%3Apmid%2F33780352&rft.externalDocID=33780352 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1945-4589&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1945-4589&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1945-4589&client=summon |